XML 22 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2024   30,202,003      
Balance at beginning of period at Dec. 31, 2024 $ 1,226,061 $ 298 $ 384,932 $ 982,304 $ (141,473)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income (Loss) (68,100)     (68,100)  
Other comprehensive income (loss), net of tax 33,108       33,108
Stock-based compensation expense 3,797   3,797    
Issuance of common stock under share-based compensation arrangements (in shares)   153,718      
Issuance of common stock under share-based compensation arrangements 0 $ 2 (2)    
Issuance of common stock related to employee stock purchase plan (in shares)   9,262      
Issuance of common stock related to employee stock purchase plan 200   200    
Cash dividends declared (9,999)     (9,999)  
Ending balance (in shares) at Jun. 30, 2025   30,364,983      
Balance at end of period at Jun. 30, 2025 1,185,067 $ 300 388,927 904,205 (108,365)
Beginning balance (in shares) at Mar. 31, 2025   30,368,843      
Balance at beginning of period at Mar. 31, 2025 1,244,891 $ 300 386,535 978,995 (120,939)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income (Loss) (69,775)     (69,775)  
Other comprehensive income (loss), net of tax 12,574       12,574
Stock-based compensation expense 2,273   2,273    
Issuance of common stock under share-based compensation arrangements (in shares)   9,518      
Issuance of common stock under share-based compensation arrangements 0        
Issuance of common stock related to employee stock purchase plan (in shares)   5,658      
Issuance of common stock related to employee stock purchase plan 119   119    
Cash dividends declared (5,015)     (5,015)  
Ending balance (in shares) at Jun. 30, 2025   30,364,983      
Balance at end of period at Jun. 30, 2025 $ 1,185,067 $ 300 388,927 904,205 (108,365)
Beginning balance (in shares) at Dec. 31, 2025 30,359,632 30,359,632      
Balance at beginning of period at Dec. 31, 2025 $ 1,131,283 $ 300 382,499 837,643 (89,159)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income (Loss) 21,636     21,636  
Other comprehensive income (loss), net of tax (4,320)       (4,320)
Stock-based compensation expense 3,464   3,464    
Issuance of common stock under share-based compensation arrangements (in shares)   121,040      
Issuance of common stock under share-based compensation arrangements (1,146) $ 2 (1,081) (67)  
Issuance of common stock related to employee stock purchase plan (in shares)   9,737      
Issuance of common stock related to employee stock purchase plan 200   200    
Cash dividends declared $ (611)     (611)  
Ending balance (in shares) at Jun. 30, 2026 30,490,409 30,490,409      
Balance at end of period at Jun. 30, 2026 $ 1,150,506 $ 302 385,082 858,601 (93,479)
Beginning balance (in shares) at Mar. 31, 2026   30,494,659      
Balance at beginning of period at Mar. 31, 2026 1,145,277 $ 302 383,050 851,998 (90,073)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income (Loss) 6,918     6,918  
Other comprehensive income (loss), net of tax (3,406)       (3,406)
Stock-based compensation expense 1,953   1,953    
Issuance of common stock under share-based compensation arrangements (in shares)   10,172      
Issuance of common stock under share-based compensation arrangements (51)   (44) (7)  
Issuance of common stock related to employee stock purchase plan (in shares)   5,922      
Issuance of common stock related to employee stock purchase plan 123   123    
Cash dividends declared $ (308)     (308)  
Ending balance (in shares) at Jun. 30, 2026 30,490,409 30,490,409      
Balance at end of period at Jun. 30, 2026 $ 1,150,506 $ 302 $ 385,082 $ 858,601 $ (93,479)